{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:39:58Z","timestamp":1760852398191,"version":"3.28.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[1995,10,1]],"date-time":"1995-10-01T00:00:00Z","timestamp":812505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1995,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>A number of carboxylate esters of L-dopa, some of which are novel, were examined for their physicochemical and biological properties. A few esters of tyrosine and phenylalanine were included for comparison.<\/jats:p>\n               <jats:p>The compounds displayed great differences in their lipophilicity and stability towards chemical and enzymatic (human plasma) hydrolysis. Within subseries, relationships exist between structural properties and rate constants of chemical or enzymatic hydrolysis. In an experimental model of hemiparkinsonism (circling behaviour in rats), some of the L-dopa esters (the isopropyl, sec-butyl and 2-(tetrahydropyr-anyl)methyl esters) showed an activity distinctly greater than that of L-dopa, although the difference was not statistically significant.<\/jats:p>","DOI":"10.1111\/j.2042-7158.1995.tb05755.x","type":"journal-article","created":{"date-parts":[[2011,4,13]],"date-time":"2011-04-13T13:07:10Z","timestamp":1302700030000},"page":"861-869","source":"Crossref","is-referenced-by-count":19,"title":["Esters of L-Dopa: Structure-hydrolysis Relationships and Ability to Induce Circling Behaviour in an Experimental Model of Hemiparkinsonism"],"prefix":"10.1093","volume":"47","author":[{"given":"Michele","family":"Brunner-Guenat","sequence":"first","affiliation":[{"name":"Institut de Chimie Th\u00e9rapeutique, Section de Pharmacie, Universit\u00e9 de Lausanne , CH-1015 Lausanne,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Alain","family":"Carrupt","sequence":"additional","affiliation":[{"name":"Institut de Chimie Th\u00e9rapeutique, Section de Pharmacie, Universit\u00e9 de Lausanne , CH-1015 Lausanne,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Lisa","sequence":"additional","affiliation":[{"name":"Institut de Chimie Th\u00e9rapeutique, Section de Pharmacie, Universit\u00e9 de Lausanne , CH-1015 Lausanne,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Testa","sequence":"additional","affiliation":[{"name":"Institut de Chimie Th\u00e9rapeutique, Section de Pharmacie, Universit\u00e9 de Lausanne , CH-1015 Lausanne,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Rose","sequence":"additional","affiliation":[{"name":"Neurodegenerative Diseases Research Centre, Pharmacology Group, Biomedical Sciences Division, King's College London , Manresa Road, London SW3 6LX,","place":["UK"]},{"name":"Institut de Chimie Th\u00e9rapeutique, Section de Pharmacie, Universit\u00e9 de Lausanne , CH-1015 Lausanne,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerrie","family":"Thomas","sequence":"additional","affiliation":[{"name":"Neurodegenerative Diseases Research Centre, Pharmacology Group, Biomedical Sciences Division, King's College London , Manresa Road, London SW3 6LX,","place":["UK"]},{"name":"Institut de Chimie Th\u00e9rapeutique, Section de Pharmacie, Universit\u00e9 de Lausanne , CH-1015 Lausanne,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Jenner","sequence":"additional","affiliation":[{"name":"Neurodegenerative Diseases Research Centre, Pharmacology Group, Biomedical Sciences Division, King's College London , Manresa Road, London SW3 6LX,","place":["UK"]},{"name":"Institut de Chimie Th\u00e9rapeutique, Section de Pharmacie, Universit\u00e9 de Lausanne , CH-1015 Lausanne,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Ventura","sequence":"additional","affiliation":[{"name":"Chiesi Farmaceutici Spa , Via Palermo, I-43100 Parma,","place":["Italy"]},{"name":"Institut de Chimie Th\u00e9rapeutique, Section de Pharmacie, Universit\u00e9 de Lausanne , CH-1015 Lausanne,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1995,10,1]]},"reference":[{"key":"2024103110220884700_cit1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.2042-7158.1980.tb12991.x","article-title":"Aspirin binding and the effect of albumin on spontaneous and enzyme-catalysed hydrolysis","volume":"32","author":"Aarons","year":"1980","journal-title":"J. Pharm. Pharmacol."},{"key":"2024103110220884700_cit2","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1042\/bj0500690","article-title":"Quantitative studies of the acidity of naturally occurring substances. II. Amino acids having three ionizing groups","volume":"50","author":"Albert","year":"1952","journal-title":"Biochem. J."},{"volume-title":"Deriv\u00e9s O-Alkyl\u00e9s de la Dihydroxy-3,4-phenylalanine","year":"1977","author":"Barth","key":"2024103110220884700_cit3"},{"key":"2024103110220884700_cit4","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1021\/jm00221a014","article-title":"Improved delivery through biological membranes. 4. Prodrugs of L-Dopa","volume":"20","author":"Bodor","year":"1977","journal-title":"J. Med. Chem."},{"key":"2024103110220884700_cit5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0378-5173(86)90034-7","article-title":"Prodrugs of timolol for improved ocular delivery: synthesis, hydrolysis kinetics and lipophilicity of various timolol esters","volume":"33","author":"Bundgaard","year":"1986","journal-title":"Int. J. Pharm."},{"key":"2024103110220884700_cit6","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.2042-7158.1987.tb03441.x","article-title":"L-Dopa esters as potential prodrugs: behavioural activity in experimental models of Parkinson's disease","volume":"39","author":"Cooper","year":"1987","journal-title":"J. Pharm. Pharmacol."},{"key":"2024103110220884700_cit7","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.2042-7158.1987.tb05123.x","article-title":"L-Dopa esters as potential prodrugs: effect on brain concentration of dopamine metabolites in reserpinized mice","volume":"39","author":"Cooper","year":"1987","journal-title":"J. Pharm. Pharmacol."},{"key":"2024103110220884700_cit8","first-page":"2896","article-title":"Polypeptides Part XII: the preparation of 2-pyridyl esters and their use in peptide synthesis","volume-title":"J. Chem. Soc. (C)","author":"Dutta","year":"1971"},{"key":"2024103110220884700_cit9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0021-9673(01)90508-4","article-title":"Lipophilicity measurements of protonated basic compounds by reversed-phase high-performance liquid chromatography. II. Procedure for the determination of a lipophilic index measured by RP-HPLC","volume":"320","author":"El Tayar","year":"1985","journal-title":"J. Chromatogr."},{"key":"2024103110220884700_cit10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1039\/P29920000079","article-title":"Octan-l-ol-water partition coefficients of zwitterionic \u03b1-amino acids. Determination by centrifugal partition chromatography and factorization into steric\/hydrophobic and polar components. J","volume":"2","author":"El Tayar","year":"1992","journal-title":"Chem. Soc. P.T."},{"key":"2024103110220884700_cit11","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1021\/jm00250a011","article-title":"Synthesis and antireserperine activity of peptides of L-dopa","volume":"17","author":"Felix","year":"1974","journal-title":"J. Med. Chem."},{"key":"2024103110220884700_cit12","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1023\/A:1015924724973","article-title":"Short-chain alkyl esters of L-dopa as prodrugs for rectal absorption","volume":"6","author":"Fix","year":"1989","journal-title":"Pharm. Res."},{"key":"2024103110220884700_cit13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1023\/A:1015823523388","article-title":"A comparison or oral and rectal absorption of L-Dopa esters in rats and mice","volume":"7","author":"Fix","year":"1990","journal-title":"Pharm. Res."},{"key":"2024103110220884700_cit14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00119860","article-title":"Molecular lipophilicity potential, a tool in 3D QSAR: method and applications","volume":"8","author":"Gaillard","year":"1994","journal-title":"J. Comput.-Aided Molec. Design"},{"key":"2024103110220884700_cit15","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0960-894X(01)80191-8","article-title":"The conformation-dependent lipophilicity of morphine glucuronides as calculated from their molecular lipophilicity potential","volume":"4","author":"Gaillard","year":"1994","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2024103110220884700_cit16","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.38.5.712","article-title":"Response to brief levodopa infusions in Parkinsonian patients with and without motor fluctuations","volume":"38","author":"Gancher","year":"1988","journal-title":"Neurology"},{"key":"2024103110220884700_cit17","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1021\/jm00155a018","article-title":"A lymphotrophic prodrug of L-dopa: synthesis, pharmacological properties, and pharmacokinetic behaviour of 1,3-dihexadecanoyl-2-[(S)-2-amino-3-(3 4-dihydroxyphenyl)propanoyl] propane-1,2,3-triol","volume":"29","author":"Garzon-Aburbeh","year":"1986","journal-title":"J. Med Chem."},{"key":"2024103110220884700_cit18","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1021\/ja00354a007","article-title":"The calculation of molecular volumes and the use of volume analysis in the investigation of structured media and of solid-state organic reactivity","volume":"105","author":"Gavezzotti","year":"1983","journal-title":"J. Am. Chem. Soc."},{"key":"2024103110220884700_cit19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jps.2600780703","article-title":"A new potential prodrug to improve the duration of L-Dopa: L-3-(3-hydroxy-4-pivaloyloxy-phenyl)alanine","volume":"78","author":"Ihara","year":"1989","journal-title":"J. Pharm. Sci."},{"key":"2024103110220884700_cit20","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0039-9140(83)80204-5","article-title":"Structure-ionization relationships of tyrosine-containing peptides","volume":"30","author":"Ishimitsu","year":"1983","journal-title":"Talanta"},{"key":"2024103110220884700_cit21","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1021\/jo00224a051","article-title":"General synthesis of chiral piperazines from amino acids","volume":"50","author":"Jung","year":"1985","journal-title":"J. Org. Chem."},{"volume-title":"The Rat Brain: a Stereotaxic Atlas of the Forebrain and Lower Parts of the Brainstem","year":"1963","author":"K\u00f6nig","key":"2024103110220884700_cit22"},{"key":"2024103110220884700_cit23","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/jps.2600620340","article-title":"New compounds: synthesis of alkyl esters of L-dopa","volume":"62","author":"Lai","year":"1973","journal-title":"J. Pharm. Sci."},{"key":"2024103110220884700_cit24","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1021\/cr00020a001","article-title":"Calculating log Poct from structures","volume":"93","author":"Leo","year":"1993","journal-title":"Chem. Rev."},{"key":"2024103110220884700_cit25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"2024103110220884700_cit26","first-page":"459","article-title":"L-Dopa esters as potential prodrugs. Physicochemical properties","volume":"20","author":"Marrel","year":"1985","journal-title":"Eur. J. Med. Chem."},{"key":"2024103110220884700_cit27","first-page":"467","article-title":"L-Dopa esters as potential prodrugs. Chemical and enzymatic hydrolysis","volume":"20","author":"Marrel","year":"1985","journal-title":"Eur. J. Med. Chem."},{"key":"2024103110220884700_cit28","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(76)91416-1","article-title":"On-off effects in patients with Parkinson's disease on chronic levodopa therapy","volume":"1","author":"Marsden","year":"1976","journal-title":"Lancet"},{"key":"2024103110220884700_cit29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0165-6147(93)90082-U","article-title":"Is L-dopa an endogenous neurotransmitter","volume":"14","author":"Misu","year":"1993","journal-title":"Trends Pharmacol. Sci."},{"key":"2024103110220884700_cit30","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/00002826-198808000-00007","article-title":"Hypothesis: central mechanisms and levodopa response fluctuations in Parkinson's disease","volume":"11","author":"Mouradian","year":"1988","journal-title":"Clin. Neuropharmacol."},{"key":"2024103110220884700_cit31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1471-4159.1992.tb09286.x","article-title":"Decarboxylation of exogenous L-3,4-dihydroxyphenylalanine in rat striatum as studied by in-vivo voltammetry","volume":"58","author":"Nakazato","year":"1992","journal-title":"J. Neurochem."},{"key":"2024103110220884700_cit32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00002826-198403000-00002","article-title":"Pharmacokinetics of levodopa","volume":"7","author":"Nutt","year":"1984","journal-title":"Clin. Neuropharmacol."},{"key":"2024103110220884700_cit33","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1212\/WNL.36.6.739","article-title":"Levodopa pharmacokinetics and pharmacodynamics in fluctuating Parkinsonian patients","volume":"36","author":"Nutt","year":"1986","journal-title":"Neurology"},{"key":"2024103110220884700_cit34","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1056\/NEJM198402233100802","article-title":"The on-off phenomenon in Parkinson's disease","volume":"310","author":"Nutt","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"2024103110220884700_cit35","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1212\/WNL.34.9.1131","article-title":"Control of on\/off phenomenon by continuous intravenous infusion of levodopa","volume":"34","author":"Quinn","year":"1984","journal-title":"Neurology"},{"key":"2024103110220884700_cit36","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1212\/WNL.39.7.888","article-title":"Continuous levodopa infusions to treat complex dystonia in Parkinson's disease","volume":"39","author":"Sage","year":"1989","journal-title":"Neurology"},{"key":"2024103110220884700_cit37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0378-5173(92)90260-9","article-title":"Physico-chemical properties and transport behaviour of piribedil: considerations on its membrane-crossing potential","volume":"80","author":"Tsai","year":"1992","journal-title":"Int. J. Pharmaceut."},{"key":"2024103110220884700_cit38","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00002826-198910000-00004","article-title":"NB-355: a novel prodrug for L-dopa with reduced risk for peak-dose dyskinesias in MPTP-treated squirrel monkeys","volume":"12","author":"Tye","year":"1989","journal-title":"Clin. Neuropharmacol."},{"key":"2024103110220884700_cit39","first-page":"85","article-title":"The parametrization of lipophilicity and other structural properties in drug design","volume-title":"Advances in Drug Research","author":"Van de Waterbeemd","year":"1987"},{"key":"2024103110220884700_cit40","first-page":"135","article-title":"Multivariate statistical analysis of L-dopa esters as potential anti-parkinsonian prodrugs","volume":"2","author":"Van de Waterbeemd","year":"1987","journal-title":"Drug Des. Deliv."},{"key":"2024103110220884700_cit41","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1471-4159.1991.tb02585.x","article-title":"Effect of precursor loading on the synthesis rate and release of dopamine and serotonin in the striatum: a microdialysis study in conscious rats","volume":"56","author":"Westerink","year":"1991","journal-title":"J. Neurochem."}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.2042-7158.1995.tb05755.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/47\/10\/861\/60266204\/j.2042-7158.1995.tb05755.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/47\/10\/861\/60266204\/j.2042-7158.1995.tb05755.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T10:56:32Z","timestamp":1730372192000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/47\/10\/861\/6152498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,10,1]]},"references-count":41,"journal-issue":{"issue":"10","published-online":{"date-parts":[[1995,10,1]]},"published-print":{"date-parts":[[1995,10,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.2042-7158.1995.tb05755.x","relation":{},"ISSN":["2042-7158","0022-3573"],"issn-type":[{"type":"electronic","value":"2042-7158"},{"type":"print","value":"0022-3573"}],"subject":[],"published-other":{"date-parts":[[1995,10]]},"published":{"date-parts":[[1995,10,1]]}}}